Japanese encephalitis virus — Drug Target

All drugs that target Japanese encephalitis virus — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Inactivated viral vaccine · Live attenuated vaccine

Phase 3 pipeline (2)

• IC51 Japanese Encephalitis · Valneva Austria GmbH · Inactivated viral vaccine · Infectious Disease / Immunology
  IC51 is an inactivated Japanese encephalitis virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.
• IMOJEV · SK Bioscience Co., Ltd. · Live attenuated vaccine · Infectious Disease / Immunology
  IMOJEV is a live attenuated Japanese encephalitis virus vaccine that stimulates immune responses to prevent Japanese encephalitis infection.